Visen Pharmaceuticals files board, board committee and disclosure-responsible management list

• Visen Pharmaceuticals updated its board and committee roster dated Aug. 27, 2026, naming Fu Shan as board chairman.
• Board lineup set as one executive director, five non-executive directors, three independent non-executive directors.
• Audit committee chaired by Chen Bingjun; members include Michael J. Chang, Zhang Qing.
• Remuneration committee chaired by Ni Hong; members include Lu Anbang, Chen Bingjun.
• Nomination committee chaired by Fu Shan; members include Ni Hong, Zhang Qing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visen Pharmaceuticals published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303430), on August 27, 2026, and is solely responsible for the information contained therein.